Women’s health companies develop diagnostics, therapies and technologies addressing health needs across different stages of life. Their work spans reproductive health, fertility, pregnancy, menopause and conditions that disproportionately or uniquely affect women.
This category includes companies working on:
Browse 46 UK women’s health companies below.
Electrochemical lateral flow diagnostics for accessible at-home health testing
éclateral is a UK-based developer of electrochemical lateral flow diagnostic technology for at-home and point-of-care testing. The company's portable reader pairs with adapted lateral flow test cassettes and a companion mobile app to deliver quantitative, sensitive results beyond standard optical lateral flow…
Endometrial biology platform for implantation failure and miscarriage
Sita Bio is a London-based biotechnology company engineering functional, vascularised thick living tissue. Combining tissue engineering, vascular biology, perfusion hardware and automated experimentation, it builds living systems that survive, organise and adapt. Its first application is a first-trimester uterine…
Oral iron deficiency therapy for adults across multiple indications
Shield Therapeutics is a commercial-stage specialty pharmaceutical company focused on iron deficiency. Its lead product, Accrufer/Feraccru (ferric maltol), is an oral iron therapy approved for adults with iron deficiency with or without anaemia. The product is commercialised in the US with Viatris and licensed to…
Oncology biotech developing peptide therapeutics and diagnostics
ValiRx is a UK-listed biopharmaceutical company focused on the development of oncology therapeutics and companion diagnostics. The company selects and incubates novel drug candidates, including peptide-based compounds targeting prostate cancer, endometriosis, and other solid tumours, progressing them from preclinical…
AI-powered infrared diagnostic test for breast cancer recurrence risk
Digistain is a biotechnology company developing MHRA-cleared diagnostic technology for predicting breast cancer recurrence risk. The platform uses infrared spectrometry to generate spectroscopic signatures from tumour biopsy tissue, with AI analysis producing a personalised prognostic score indicating the likelihood…
Therapeutics to restore egg quality and improve IVF outcomes
U-Ploid Biotechnologies is an early-stage biotechnology company developing first-in-class therapeutics to address age-related decline in egg quality. Its lead programme targets chromosomal instability in human oocytes which is a primary driver of IVF failure, miscarriage, and congenital disorders in women of advanced…
Reproductive genetic testing and embryo screening for fertility clinics
Igenomix UK is a reproductive genetics laboratory providing diagnostic testing services for fertility clinics and reproductive medicine specialists. Its services include preimplantation genetic testing for chromosomal abnormalities and inherited conditions, alongside carrier screening and endometrial assessments. The…
AI-powered ultrasound analysis software for endometriosis detection
Revela is a medical software company developing machine learning tools to assist in the diagnosis of endometriosis via analysis of ultrasound scans. The software automatically identifies subtle imaging signs associated with endometriosis and returns a structured report to the reviewing clinician, targeting earlier…
Tissue-based endometriosis models for therapeutic target discovery
Cyclana Bio is a biotechnology company developing human tissue-based models to investigate endometriosis and identify therapeutic targets. Its research combines endometrial tissue biopsies and menstrual fluid samples with molecular profiling and three-dimensional disease models, focusing on extracellular matrix…
Clinical skin microbiome testing and multi-omic ingredient analysis platform
Sequential Skin is a biotechnology company providing non-invasive clinical microbiome testing and multi-omic analysis services to the personal care and pharmaceutical industries. Using patch-based sampling and next-generation sequencing, the company quantifies how ingredients and formulations affect the skin…
Pharmacogenomic platform for personalised hormone therapy prescribing
Dama Health is a clinical decision-support software company focused on personalised prescribing of hormone therapies in women's health. Its platform collects patient health, lifestyle, and genetic data and uses an AI-driven recommendation engine to match patients to appropriate hormone therapies and contraceptives.…
Translational CRO offering oncology and women's health assay services
Inaphaea BioLabs is a translational contract research organisation based at MediCity Nottingham, offering cell-based assays and patient-derived cell (PDC) models to support early-stage drug discovery and preclinical development. The company specialises in oncology and women's health, providing biochemical and…
AI software for embryo and sperm selection in assisted reproductive technology
IVF 2.0 is a software company developing artificial intelligence tools for use in in vitro fertilisation laboratories. Its products apply computer vision and deep learning to microscopy imagery to provide quantitative assessments of embryo and sperm quality, supporting embryologists in selection decisions that are…
Lateral flow and molecular diagnostic tests for multiple applications
AccuBio is a UK-based manufacturer of in-vitro diagnostic products, producing lateral flow assays and molecular diagnostic tests across infectious disease, toxicology, oncology, cardiovascular, and veterinary applications. Operating from manufacturing facilities in Alva, Scotland, acquired from Omega Diagnostics, the…
Non-invasive vaginal sampling for gynaecological disease
Ellele Health is a medical research company developing a minimally invasive vaginal sampling device and associated downstream assays for the detection and management of gynaecological conditions. Using a proprietary biospecimen collected from the vaginal wall, the company applies genetic, epigenomic, and microbial…
IgE and IgA antibody therapeutics for cancer treatment
Epsilogen is a clinical-stage biotech pioneering the development of non-IgG immunoglobulin antibody therapeutics for cancer. The company's platform spans IgE, IgA, and IgG isotypes, enabling selection of the most appropriate antibody format for a given tumour type. Its lead candidate MOv18 IgE, the first IgE antibody…
Human ovarian cell models and multi-omics drug discovery
OvartiX is a Cambridge biotechnology company developing drug-discovery tools and therapeutic programmes for ovarian and reproductive health. Its platform combines human multi-omics datasets, machine learning and engineered two- and three-dimensional ovarian cell models to identify and validate disease targets. Founded…
Global biopharmaceutical company developing therapies for serious diseases
AbbVie is a global research-based biopharmaceutical company focused on the discovery, development and commercialisation of medicines across immunology, oncology, neuroscience and aesthetics. Its portfolio includes treatments for autoimmune diseases, haematological cancers, neurological conditions and women's health.…
Mitochondrial DNA liquid biopsy tests for cancer and disease detection
MDNA Life Sciences is a biotechnology company developing proprietary diagnostic tests based on mitochondrial DNA biomarkers. Its technology detects specific mitochondrial DNA deletions in blood and tissue samples as indicators of disease, enabling non-invasive testing for conditions that are difficult to diagnose.…
Intra-uterine sensor platform for continuous uterine biomarker monitoring
Verso Biosense is a femtech medtech company developing a miniaturised intra-uterine sensor device for continuous physiological monitoring of the uterus. The battery-free implantable device measures temperature, dissolved oxygen, and pH in real time, transmitting data wirelessly to a proprietary software platform.…